EC: 2.7.10.1
receptor protein-tyrosine kinase (ATP:[protein]-L-tyrosine O-phosphotransferase (receptor-type))
Pathways
| pathway id | name |
|---|---|
| BioCyc:MOUSE_PWY3DJ-5523 | sucrose degradation |
| BioCyc:MOUSE_PWY-842 | starch degradation |
| Reactome:R-HSA-9607240 | FLT3 Signaling |
| Reactome:R-HSA-9664565 | Signaling by ERBB2 KD Mutants |
| Reactome:R-HSA-9665244 | Resistance of ERBB2 KD mutants to sapitinib |
| Reactome:R-HSA-9652282 | Drug-mediated inhibition of ERBB2 signaling |
| Reactome:R-HSA-8853884 | Transcriptional Regulation by VENTX |
| Reactome:R-HSA-9634285 | Constitutive Signaling by Overexpressed ERBB2 |
| Reactome:R-HSA-9665245 | Resistance of ERBB2 KD mutants to tesevatinib |
| Reactome:R-MMU-9607240 | FLT3 Signaling |
| Reactome:R-HSA-1227990 | Signaling by ERBB2 in Cancer |
| Reactome:R-HSA-9665249 | Resistance of ERBB2 KD mutants to afatinib |
| Reactome:R-HSA-9665230 | Drug resistance in ERBB2 KD mutants |
| Reactome:R-SSC-9675108 | Nervous system development |
| Reactome:R-HSA-9671555 | Signaling by PDGFR in disease |
| Reactome:R-HSA-9673768 | Signaling by membrane-tethered fusions of PDGFRA or PDGFRB |
| Reactome:R-HSA-9674401 | Sunitinib-resistant PDGFR mutants |
| Reactome:R-HSA-9669938 | Signaling by KIT in disease |
| Reactome:R-RNO-9652282 | Drug-mediated inhibition of ERBB2 signaling |
| Reactome:R-HSA-9706374 | FLT3 signaling through SRC family kinases |
| Reactome:R-HSA-9702506 | Drug resistance of FLT3 mutants |
| Reactome:R-HSA-9703009 | tamatinib-resistant FLT3 mutants |
| Reactome:R-HSA-9702590 | gilteritinib-resistant FLT3 mutants |
| Reactome:R-DRE-201556 | Signaling by ALK |
| Reactome:R-MMU-201556 | Signaling by ALK |
| Reactome:R-HSA-9700206 | Signaling by ALK in cancer |
| Reactome:R-HSA-9700649 | Drug resistance of ALK mutants |
| Reactome:R-HSA-9717301 | NVP-TAE684-resistant ALK mutants |
| Reactome:R-RNO-9734091 | Drug-mediated inhibition of MET activation |
| Reactome:R-MMU-9734091 | Drug-mediated inhibition of MET activation |
| Reactome:R-HSA-9734091 | Drug-mediated inhibition of MET activation |
| Reactome:R-HSA-9758941 | Gastrulation |
| Reactome:R-HSA-9758919 | Epithelial-Mesenchymal Transition (EMT) during gastrulation |
| Reactome:R-HSA-9824439 | Bacterial Infection Pathways |
| Reactome:R-HSA-9824272 | Somitogenesis |
| Reactome:R-CFA-9851151 | MDK and PTN in ALK signaling |
| Reactome:R-HSA-9830369 | Kidney development |
| Reactome:R-MMU-9851151 | MDK and PTN in ALK signaling |
| Reactome:R-CFA-9856649 | Transcriptional and post-translational regulation of MITF-M expression and activity |
| Reactome:R-GGA-9730414 | MITF-M-regulated melanocyte development |
| Reactome:R-HSA-9856651 | MITF-M-dependent gene expression |
| Reactome:R-MMU-9856649 | Transcriptional and post-translational regulation of MITF-M expression and activity |
| Reactome:R-CEL-9675108 | Nervous system development |
| Reactome:R-MMU-9675108 | Nervous system development |
| Reactome:R-HSA-9675108 | Nervous system development |
| Reactome:R-HSA-9680187 | Signaling by extracellular domain mutants of KIT |
| Reactome:R-MMU-9652282 | Drug-mediated inhibition of ERBB2 signaling |
| Reactome:R-HSA-9702600 | midostaurin-resistant FLT3 mutants |
| Reactome:R-HSA-9702998 | linifanib-resistant FLT3 mutants |
| Reactome:R-CFA-201556 | Signaling by ALK |
| Reactome:R-HSA-9717316 | alectinib-resistant ALK mutants |
| Reactome:R-HSA-9717329 | lorlatinib-resistant ALK mutants |
| Reactome:R-SSC-9734091 | Drug-mediated inhibition of MET activation |
| Reactome:R-HSA-9793380 | Formation of paraxial mesoderm |
| Reactome:R-DRE-9851151 | MDK and PTN in ALK signaling |
| Reactome:R-CFA-9730414 | MITF-M-regulated melanocyte development |
| Reactome:R-DRE-9856649 | Transcriptional and post-translational regulation of MITF-M expression and activity |
| Reactome:R-HSA-9856649 | Transcriptional and post-translational regulation of MITF-M expression and activity |
| Reactome:R-MMU-9730414 | MITF-M-regulated melanocyte development |
| Reactome:R-HSA-9665348 | Signaling by ERBB2 ECD mutants |
| Reactome:R-HSA-9674403 | Regorafenib-resistant PDGFR mutants |
| Reactome:R-CEL-9652282 | Drug-mediated inhibition of ERBB2 signaling |
| Reactome:R-MMU-9706374 | FLT3 signaling through SRC family kinases |
| Reactome:R-HSA-9706369 | Negative regulation of FLT3 |
| Reactome:R-HSA-9706377 | FLT3 signaling by CBL mutants |
| Reactome:R-HSA-9702581 | crenolanib-resistant FLT3 mutants |
| Reactome:R-HSA-9702596 | lestaurtinib-resistant FLT3 mutants |
| Reactome:R-HSA-9725370 | Signaling by ALK fusions and activated point mutants |
| Reactome:R-HSA-9717326 | crizotinib-resistant ALK mutants |
| Reactome:R-HSA-9717319 | brigatinib-resistant ALK mutants |
| Reactome:R-HSA-201556 | Signaling by ALK |
| Reactome:R-HSA-9634815 | Transcriptional Regulation by NPAS4 |
| Reactome:R-HSA-9768919 | NPAS4 regulates expression of target genes |
| Reactome:R-HSA-9680350 | Signaling by CSF1 (M-CSF) in myeloid cells |
| Reactome:R-HSA-9830364 | Formation of the nephric duct |
| Reactome:R-GGA-9856649 | Transcriptional and post-translational regulation of MITF-M expression and activity |
| Reactome:R-HSA-9842663 | Signaling by LTK |
| Reactome:R-RNO-9675108 | Nervous system development |
| Reactome:R-DME-9675108 | Nervous system development |
| Reactome:R-HSA-9665686 | Signaling by ERBB2 TMD/JMD mutants |
| Reactome:R-HSA-9673770 | Signaling by PDGFRA extracellular domain mutants |
| Reactome:R-HSA-9674415 | Drug resistance of PDGFR mutants |
| Reactome:R-CEL-190322 | FGFR4 ligand binding and activation |
| Reactome:R-HSA-9669935 | Signaling by juxtamembrane domain KIT mutants |
| Reactome:R-DME-9652282 | Drug-mediated inhibition of ERBB2 signaling |
| Reactome:R-MMU-9706369 | Negative regulation of FLT3 |
| Reactome:R-HSA-9682385 | FLT3 signaling in disease |
| Reactome:R-HSA-9702577 | semaxanib-resistant FLT3 mutants |
| Reactome:R-HSA-9702569 | KW2449-resistant FLT3 mutants |
| Reactome:R-HSA-9717323 | ceritinib-resistant ALK mutants |
| Reactome:R-HSA-9717264 | ASP-3026-resistant ALK mutants |
| Reactome:R-HSA-9830674 | Formation of the ureteric bud |
| Reactome:R-HSA-9851151 | MDK and PTN in ALK signaling |
| Reactome:R-DRE-9730414 | MITF-M-regulated melanocyte development |
| Reactome:R-HSA-9730414 | MITF-M-regulated melanocyte development |
| Reactome:R-HSA-9825892 | Regulation of MITF-M-dependent genes involved in cell cycle and proliferation |
| Reactome:R-MMU-9842663 | Signaling by LTK |
| Reactome:R-HSA-9856530 | High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells |
| Reactome:R-HSA-9860931 | Response of endothelial cells to shear stress |
| Reactome:R-HSA-9855142 | Cellular responses to mechanical stimuli |
| Reactome:R-CEL-190370 | FGFR1b ligand binding and activation |
| Reactome:R-CEL-5654693 | FRS-mediated FGFR1 signaling |
| Reactome:R-CEL-5654726 | Negative regulation of FGFR1 signaling |
| Reactome:R-CEL-190372 | FGFR3c ligand binding and activation |
| Reactome:R-CEL-5654716 | Downstream signaling of activated FGFR4 |
| Reactome:R-CEL-5654733 | Negative regulation of FGFR4 signaling |
| Reactome:R-CEL-180292 | GAB1 signalosome |
| Reactome:R-CEL-5654687 | Downstream signaling of activated FGFR1 |
| Reactome:R-CEL-190375 | FGFR2c ligand binding and activation |
| Reactome:R-CEL-190371 | FGFR3b ligand binding and activation |
| Reactome:R-CEL-5654743 | Signaling by FGFR4 |
| Reactome:R-CEL-8863795 | Downregulation of ERBB2 signaling |
| Reactome:R-RNO-9009391 | Extra-nuclear estrogen signaling |
| Reactome:R-DME-190374 | FGFR1c and Klotho ligand binding and activation |
| Reactome:R-DME-9009391 | Extra-nuclear estrogen signaling |
| Reactome:R-MMU-8852405 | Signaling by MST1 |
| Reactome:R-HSA-9634638 | Estrogen-dependent nuclear events downstream of ESR-membrane signaling |
| Reactome:R-CEL-5654219 | Phospholipase C-mediated cascade: FGFR1 |
| Reactome:R-CEL-190241 | FGFR2 ligand binding and activation |
| Reactome:R-CEL-5654227 | Phospholipase C-mediated cascade; FGFR3 |
| Reactome:R-CEL-5654712 | FRS-mediated FGFR4 signaling |
| Reactome:R-DME-1963642 | PI3K events in ERBB2 signaling |
| Reactome:R-HSA-9009391 | Extra-nuclear estrogen signaling |
| Reactome:R-CEL-212718 | EGFR interacts with phospholipase C-gamma |
| Reactome:R-CEL-190377 | FGFR2b ligand binding and activation |
| Reactome:R-CEL-190239 | FGFR3 ligand binding and activation |
| Reactome:R-CEL-5654228 | Phospholipase C-mediated cascade; FGFR4 |
| Reactome:R-CEL-8847993 | ERBB2 Activates PTK6 Signaling |
| Reactome:R-CEL-9009391 | Extra-nuclear estrogen signaling |
| Reactome:R-DME-212718 | EGFR interacts with phospholipase C-gamma |
| Reactome:R-MMU-9009391 | Extra-nuclear estrogen signaling |
| Reactome:R-BTA-109582 | Hemostasis |
| Reactome:R-CEL-179812 | GRB2 events in EGFR signaling |
| Reactome:R-CEL-5654736 | Signaling by FGFR1 |
| Reactome:R-CEL-6785631 | ERBB2 Regulates Cell Motility |
| Reactome:R-CEL-1253288 | Downregulation of ERBB4 signaling |
| Reactome:R-CEL-8848021 | Signaling by PTK6 |
| Reactome:R-CEL-422475 | Axon guidance |
| Reactome:R-CEL-3928665 | EPH-ephrin mediated repulsion of cells |
| Reactome:R-CEL-1474244 | Extracellular matrix organization |
| Reactome:R-CFA-162582 | Signaling Pathways |
| Reactome:R-CFA-1433557 | Signaling by SCF-KIT |
| Reactome:R-DRE-9006934 | Signaling by Receptor Tyrosine Kinases |
| Reactome:R-DRE-5654736 | Signaling by FGFR1 |
| Reactome:R-DRE-190374 | FGFR1c and Klotho ligand binding and activation |
| Reactome:R-DRE-5654219 | Phospholipase C-mediated cascade: FGFR1 |
| Reactome:R-DRE-5654738 | Signaling by FGFR2 |
| Reactome:R-DRE-190375 | FGFR2c ligand binding and activation |
| Reactome:R-DRE-190239 | FGFR3 ligand binding and activation |
| Reactome:R-DRE-5654706 | FRS-mediated FGFR3 signaling |
| Reactome:R-DRE-5654716 | Downstream signaling of activated FGFR4 |
| Reactome:R-DRE-186797 | Signaling by PDGF |
| Reactome:R-DRE-195399 | VEGF binds to VEGFR leading to receptor dimerization |
| Reactome:R-DRE-1280215 | Cytokine Signaling in Immune system |
| Reactome:R-DRE-449147 | Signaling by Interleukins |
| Reactome:R-DME-9006934 | Signaling by Receptor Tyrosine Kinases |
| Reactome:R-DME-180292 | GAB1 signalosome |
| Reactome:R-DME-190242 | FGFR1 ligand binding and activation |
| Reactome:R-DME-5654687 | Downstream signaling of activated FGFR1 |
| Reactome:R-DME-195721 | Signaling by WNT |
| Reactome:R-DME-9006931 | Signaling by Nuclear Receptors |
| Reactome:R-DME-9018519 | Estrogen-dependent gene expression |
| Reactome:R-DME-5653656 | Vesicle-mediated transport |
| Reactome:R-DME-8856828 | Clathrin-mediated endocytosis |
| Reactome:R-DME-1266738 | Developmental Biology |
| Reactome:R-DME-416572 | Sema4D induced cell migration and growth-cone collapse |
| Reactome:R-DME-373760 | L1CAM interactions |
| Reactome:R-DME-110478 | Insulin signaling pathway |
| Reactome:R-HSA-422475 | Axon guidance |
| Reactome:R-HSA-416572 | Sema4D induced cell migration and growth-cone collapse |
| Reactome:R-HSA-445144 | Signal transduction by L1 |
| Reactome:R-HSA-177929 | Signaling by EGFR |
| Reactome:R-HSA-180292 | GAB1 signalosome |
| Reactome:R-HSA-5654716 | Downstream signaling of activated FGFR4 |
| Reactome:R-HSA-187706 | Signalling to p38 via RIT and RIN |
| Reactome:R-HSA-167021 | PLC-gamma1 signalling |
| Reactome:R-HSA-177504 | Retrograde neurotrophin signalling |
| Reactome:R-HSA-9026357 | NTF4 activates NTRK2 (TRKB) signaling |
| Reactome:R-HSA-9028731 | Activated NTRK2 signals through FRS2 and FRS3 |
| Reactome:R-HSA-9034015 | Signaling by NTRK3 (TRKC) |
| Reactome:R-HSA-9603381 | Activated NTRK3 signals through PI3K |
| Reactome:R-HSA-74713 | IRS activation |
| Reactome:R-HSA-77387 | Insulin receptor recycling |
| Reactome:R-HSA-194313 | VEGF ligand-receptor interactions |
| Reactome:R-HSA-5218921 | VEGFR2 mediated cell proliferation |
| Reactome:R-HSA-1227986 | Signaling by ERBB2 |
| Reactome:R-HSA-1251932 | PLCG1 events in ERBB2 signaling |
| Reactome:R-HSA-8863795 | Downregulation of ERBB2 signaling |
| Reactome:R-HSA-2428924 | IGF1R signaling cascade |
| Reactome:R-HSA-6806942 | MET Receptor Activation |
| Reactome:R-HSA-8875878 | MET promotes cell motility |
| Reactome:R-HSA-8875791 | MET activates STAT3 |
| Reactome:R-HSA-157118 | Signaling by NOTCH |
| Reactome:R-HSA-9013507 | NOTCH3 Activation and Transmission of Signal to the Nucleus |
| Reactome:R-HSA-201681 | TCF dependent signaling in response to WNT |
| Reactome:R-HSA-4086400 | PCP/CE pathway |
| Reactome:R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases |
| Reactome:R-HSA-8857538 | PTK6 promotes HIF1A stabilization |
| Reactome:R-HSA-1643685 | Disease |
| Reactome:R-HSA-5638303 | Inhibition of Signaling by Overexpressed EGFR |
| Reactome:R-HSA-5655253 | Signaling by FGFR2 in disease |
| Reactome:R-HSA-8851708 | Signaling by FGFR2 IIIa TM |
| Reactome:R-HSA-2033514 | FGFR3 mutant receptor activation |
| Reactome:R-HSA-5655291 | Signaling by FGFR4 in disease |
| Reactome:R-HSA-74160 | Gene expression (Transcription) |
| Reactome:R-HSA-73857 | RNA Polymerase II Transcription |
| Reactome:R-HSA-8866910 | TFAP2 (AP-2) family regulates transcription of growth factors and their receptors |
| Reactome:R-MMU-168256 | Immune System |
| Reactome:R-MMU-449147 | Signaling by Interleukins |
| Reactome:R-MMU-210993 | Tie2 Signaling |
| Reactome:R-MMU-400685 | Sema4D in semaphorin signaling |
| Reactome:R-MMU-8853659 | RET signaling |
| Reactome:R-MMU-162582 | Signaling Pathways |
| Reactome:R-MMU-179812 | GRB2 events in EGFR signaling |
| Reactome:R-MMU-190236 | Signaling by FGFR |
| Reactome:R-MMU-190373 | FGFR1c ligand binding and activation |
| Reactome:R-MMU-5654693 | FRS-mediated FGFR1 signaling |
| Reactome:R-MMU-190241 | FGFR2 ligand binding and activation |
| Reactome:R-MMU-190372 | FGFR3c ligand binding and activation |
| Reactome:R-MMU-5654704 | SHC-mediated cascade:FGFR3 |
| Reactome:R-MMU-190322 | FGFR4 ligand binding and activation |
| Reactome:R-MMU-5654228 | Phospholipase C-mediated cascade; FGFR4 |
| Reactome:R-MMU-166520 | Signaling by NTRKs |
| Reactome:R-MMU-187015 | Activation of TRKA receptors |
| Reactome:R-MMU-198203 | PI3K/AKT activation |
| Reactome:R-MMU-9006115 | Signaling by NTRK2 (TRKB) |
| Reactome:R-MMU-9603381 | Activated NTRK3 signals through PI3K |
| Reactome:R-MMU-186797 | Signaling by PDGF |
| Reactome:R-MMU-195399 | VEGF binds to VEGFR leading to receptor dimerization |
| Reactome:R-MMU-194306 | Neurophilin interactions with VEGF and VEGFR |
| Reactome:R-MMU-1236394 | Signaling by ERBB4 |
| Reactome:R-MMU-1253288 | Downregulation of ERBB4 signaling |
| Reactome:R-MMU-2428928 | IRS-related events triggered by IGF1R |
| Reactome:R-MMU-8851907 | MET activates PI3K/AKT signaling |
| Reactome:R-MMU-8875513 | MET interacts with TNS proteins |
| Reactome:R-MMU-6807004 | Negative regulation of MET activity |
| Reactome:R-MMU-388396 | GPCR downstream signalling |
| Reactome:R-MMU-2179392 | EGFR Transactivation by Gastrin |
| Reactome:R-MMU-9013507 | NOTCH3 Activation and Transmission of Signal to the Nucleus |
| Reactome:R-MMU-8939211 | ESR-mediated signaling |
| Reactome:R-MMU-9006927 | Signaling by Non-Receptor Tyrosine Kinases |
| Reactome:R-MMU-8856825 | Cargo recognition for clathrin-mediated endocytosis |
| Reactome:R-MMU-6794362 | Protein-protein interactions at synapses |
| Reactome:R-RNO-112316 | Neuronal System |
| Reactome:R-RNO-162582 | Signaling Pathways |
| Reactome:R-RNO-190236 | Signaling by FGFR |
| Reactome:R-RNO-190373 | FGFR1c ligand binding and activation |
| Reactome:R-RNO-5654693 | FRS-mediated FGFR1 signaling |
| Reactome:R-RNO-190322 | FGFR4 ligand binding and activation |
| Reactome:R-RNO-5654228 | Phospholipase C-mediated cascade; FGFR4 |
| Reactome:R-RNO-166520 | Signaling by NTRKs |
| Reactome:R-RNO-187015 | Activation of TRKA receptors |
| Reactome:R-RNO-198203 | PI3K/AKT activation |
| Reactome:R-RNO-9026527 | Activated NTRK2 signals through PLCG1 |
| Reactome:R-RNO-9034015 | Signaling by NTRK3 (TRKC) |
| Reactome:R-RNO-74752 | Signaling by Insulin receptor |
| Reactome:R-RNO-186763 | Downstream signal transduction |
| Reactome:R-RNO-4420097 | VEGFA-VEGFR2 Pathway |
| Reactome:R-RNO-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) |
| Reactome:R-RNO-6806834 | Signaling by MET |
| Reactome:R-RNO-9006931 | Signaling by Nuclear Receptors |
| Reactome:R-RNO-3000171 | Non-integrin membrane-ECM interactions |
| Reactome:R-RNO-109582 | Hemostasis |
| Reactome:R-RNO-202733 | Cell surface interactions at the vascular wall |
| Reactome:R-RNO-1266738 | Developmental Biology |
| Reactome:R-RNO-416550 | Sema4D mediated inhibition of cell attachment and migration |
| Reactome:R-RNO-445144 | Signal transduction by L1 |
| Reactome:R-SSC-373755 | Semaphorin interactions |
| Reactome:R-SSC-8851805 | MET activates RAS signaling |
| Reactome:R-SSC-8875656 | MET receptor recycling |
| Reactome:R-CEL-199991 | Membrane Trafficking |
| Reactome:R-CEL-8856825 | Cargo recognition for clathrin-mediated endocytosis |
| Reactome:R-CEL-177929 | Signaling by EGFR |
| Reactome:R-CEL-190236 | Signaling by FGFR |
| Reactome:R-CEL-5654738 | Signaling by FGFR2 |
| Reactome:R-CEL-5654706 | FRS-mediated FGFR3 signaling |
| Reactome:R-CEL-1251985 | Nuclear signaling by ERBB4 |
| Reactome:R-CEL-9006931 | Signaling by Nuclear Receptors |
| Reactome:R-CEL-9006927 | Signaling by Non-Receptor Tyrosine Kinases |
| Reactome:R-CEL-1266738 | Developmental Biology |
| Reactome:R-CEL-416572 | Sema4D induced cell migration and growth-cone collapse |
| Reactome:R-CEL-445144 | Signal transduction by L1 |
| Reactome:R-CEL-3928664 | Ephrin signaling |
| Reactome:R-DRE-162582 | Signaling Pathways |
| Reactome:R-DRE-190236 | Signaling by FGFR |
| Reactome:R-DRE-190373 | FGFR1c ligand binding and activation |
| Reactome:R-DRE-5654693 | FRS-mediated FGFR1 signaling |
| Reactome:R-DRE-5654726 | Negative regulation of FGFR1 signaling |
| Reactome:R-DRE-190377 | FGFR2b ligand binding and activation |
| Reactome:R-DRE-5654741 | Signaling by FGFR3 |
| Reactome:R-DRE-5654708 | Downstream signaling of activated FGFR3 |
| Reactome:R-DRE-1307965 | betaKlotho-mediated ligand binding |
| Reactome:R-DRE-194313 | VEGF ligand-receptor interactions |
| Reactome:R-DRE-1266738 | Developmental Biology |
| Reactome:R-DRE-168256 | Immune System |
| Reactome:R-DRE-449836 | Other interleukin signaling |
| Reactome:R-DME-162582 | Signaling Pathways |
| Reactome:R-DME-180336 | SHC1 events in EGFR signaling |
| Reactome:R-DME-5654736 | Signaling by FGFR1 |
| Reactome:R-DME-5654688 | SHC-mediated cascade:FGFR1 |
| Reactome:R-DME-74752 | Signaling by Insulin receptor |
| Reactome:R-DME-1236394 | Signaling by ERBB4 |
| Reactome:R-DME-8939211 | ESR-mediated signaling |
| Reactome:R-DME-400685 | Sema4D in semaphorin signaling |
| Reactome:R-GGA-9006934 | Signaling by Receptor Tyrosine Kinases |
| Reactome:R-HSA-199991 | Membrane Trafficking |
| Reactome:R-HSA-1266738 | Developmental Biology |
| Reactome:R-HSA-416550 | Sema4D mediated inhibition of cell attachment and migration |
| Reactome:R-HSA-2892247 | POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation |
| Reactome:R-HSA-3000178 | ECM proteoglycans |
| Reactome:R-HSA-216083 | Integrin cell surface interactions |
| Reactome:R-HSA-210993 | Tie2 Signaling |
| Reactome:R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases |
| Reactome:R-HSA-180336 | SHC1 events in EGFR signaling |
| Reactome:R-HSA-1307965 | betaKlotho-mediated ligand binding |
| Reactome:R-HSA-5654719 | SHC-mediated cascade:FGFR4 |
| Reactome:R-HSA-187042 | TRKA activation by NGF |
| Reactome:R-HSA-170984 | ARMS-mediated activation |
| Reactome:R-HSA-9025046 | NTF3 activates NTRK2 (TRKB) signaling |
| Reactome:R-HSA-9028335 | Activated NTRK2 signals through PI3K |
| Reactome:R-HSA-9032845 | Activated NTRK2 signals through CDK5 |
| Reactome:R-HSA-9034864 | Activated NTRK3 signals through RAS |
| Reactome:R-HSA-74751 | Insulin receptor signalling cascade |
| Reactome:R-HSA-74749 | Signal attenuation |
| Reactome:R-HSA-194138 | Signaling by VEGF |
| Reactome:R-HSA-1433559 | Regulation of KIT signaling |
| Reactome:R-HSA-1963642 | PI3K events in ERBB2 signaling |
| Reactome:R-HSA-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) |
| Reactome:R-HSA-6806834 | Signaling by MET |
| Reactome:R-HSA-8852405 | Signaling by MST1 |
| Reactome:R-HSA-372790 | Signaling by GPCR |
| Reactome:R-HSA-2179392 | EGFR Transactivation by Gastrin |
| Reactome:R-HSA-9012852 | Signaling by NOTCH3 |
| Reactome:R-HSA-9013694 | Signaling by NOTCH4 |
| Reactome:R-HSA-195721 | Signaling by WNT |
| Reactome:R-HSA-3858494 | Beta-catenin independent WNT signaling |
| Reactome:R-HSA-9006931 | Signaling by Nuclear Receptors |
| Reactome:R-HSA-6794362 | Protein-protein interactions at synapses |
| Reactome:R-HSA-5638302 | Signaling by Overexpressed Wild-Type EGFR in Cancer |
| Reactome:R-HSA-1839124 | FGFR1 mutant receptor activation |
| Reactome:R-HSA-8853336 | Signaling by plasma membrane FGFR1 fusions |
| Reactome:R-HSA-2023837 | Signaling by FGFR2 amplification mutants |
| Reactome:R-HSA-8853334 | Signaling by FGFR3 fusions in cancer |
| Reactome:R-HSA-8875360 | InlB-mediated entry of Listeria monocytogenes into host cell |
| Reactome:R-HSA-8986944 | Transcriptional Regulation by MECP2 |
| Reactome:R-HSA-449147 | Signaling by Interleukins |
| Reactome:R-MMU-1280215 | Cytokine Signaling in Immune system |
| Reactome:R-MMU-1474244 | Extracellular matrix organization |
| Reactome:R-MMU-202733 | Cell surface interactions at the vascular wall |
| Reactome:R-MMU-373755 | Semaphorin interactions |
| Reactome:R-MMU-212718 | EGFR interacts with phospholipase C-gamma |
| Reactome:R-MMU-182971 | EGFR downregulation |
| Reactome:R-MMU-190370 | FGFR1b ligand binding and activation |
| Reactome:R-MMU-5654687 | Downstream signaling of activated FGFR1 |
| Reactome:R-MMU-190371 | FGFR3b ligand binding and activation |
| Reactome:R-MMU-5654227 | Phospholipase C-mediated cascade; FGFR3 |
| Reactome:R-MMU-5654743 | Signaling by FGFR4 |
| Reactome:R-MMU-5654712 | FRS-mediated FGFR4 signaling |
| Reactome:R-MMU-187037 | Signaling by NTRK1 (TRKA) |
| Reactome:R-MMU-170984 | ARMS-mediated activation |
| Reactome:R-MMU-9034793 | Activated NTRK3 signals through PLCG1 |
| Reactome:R-MMU-74713 | IRS activation |
| Reactome:R-MMU-77387 | Insulin receptor recycling |
| Reactome:R-MMU-194313 | VEGF ligand-receptor interactions |
| Reactome:R-MMU-5218921 | VEGFR2 mediated cell proliferation |
| Reactome:R-MMU-1227986 | Signaling by ERBB2 |
| Reactome:R-MMU-1306955 | GRB7 events in ERBB2 signaling |
| Reactome:R-MMU-1358803 | Downregulation of ERBB2:ERBB3 signaling |
| Reactome:R-MMU-1251985 | Nuclear signaling by ERBB4 |
| Reactome:R-MMU-2428933 | SHC-related events triggered by IGF1R |
| Reactome:R-MMU-8851805 | MET activates RAS signaling |
| Reactome:R-MMU-8874081 | MET activates PTK2 signaling |
| Reactome:R-MMU-8875656 | MET receptor recycling |
| Reactome:R-MMU-881907 | Gastrin-CREB signalling pathway via PKC and MAPK |
| Reactome:R-MMU-9012852 | Signaling by NOTCH3 |
| Reactome:R-MMU-8857538 | PTK6 promotes HIF1A stabilization |
| Reactome:R-MMU-8856828 | Clathrin-mediated endocytosis |
| Reactome:R-RNO-6794362 | Protein-protein interactions at synapses |
| Reactome:R-RNO-190370 | FGFR1b ligand binding and activation |
| Reactome:R-RNO-5654687 | Downstream signaling of activated FGFR1 |
| Reactome:R-RNO-5654743 | Signaling by FGFR4 |
| Reactome:R-RNO-5654712 | FRS-mediated FGFR4 signaling |
| Reactome:R-RNO-187037 | Signaling by NTRK1 (TRKA) |
| Reactome:R-RNO-170984 | ARMS-mediated activation |
| Reactome:R-RNO-9006115 | Signaling by NTRK2 (TRKB) |
| Reactome:R-RNO-9603381 | Activated NTRK3 signals through PI3K |
| Reactome:R-RNO-186797 | Signaling by PDGF |
| Reactome:R-RNO-195399 | VEGF binds to VEGFR leading to receptor dimerization |
| Reactome:R-RNO-194306 | Neurophilin interactions with VEGF and VEGFR |
| Reactome:R-RNO-1236394 | Signaling by ERBB4 |
| Reactome:R-RNO-2428928 | IRS-related events triggered by IGF1R |
| Reactome:R-RNO-8851907 | MET activates PI3K/AKT signaling |
| Reactome:R-RNO-8875513 | MET interacts with TNS proteins |
| Reactome:R-RNO-6807004 | Negative regulation of MET activity |
| Reactome:R-RNO-8939211 | ESR-mediated signaling |
| Reactome:R-RNO-168256 | Immune System |
| Reactome:R-RNO-449147 | Signaling by Interleukins |
| Reactome:R-RNO-400685 | Sema4D in semaphorin signaling |
| Reactome:R-RNO-8853659 | RET signaling |
| Reactome:R-SSC-422475 | Axon guidance |
| Reactome:R-SSC-9006934 | Signaling by Receptor Tyrosine Kinases |
| Reactome:R-SSC-6806942 | MET Receptor Activation |
| Reactome:R-SSC-8875878 | MET promotes cell motility |
| Reactome:R-SSC-8875791 | MET activates STAT3 |
| Reactome:R-BTA-202733 | Cell surface interactions at the vascular wall |
| Reactome:R-CEL-162582 | Signaling Pathways |
| Reactome:R-CEL-190242 | FGFR1 ligand binding and activation |
| Reactome:R-CEL-5654741 | Signaling by FGFR3 |
| Reactome:R-CEL-1227986 | Signaling by ERBB2 |
| Reactome:R-CEL-1236394 | Signaling by ERBB4 |
| Reactome:R-CEL-373755 | Semaphorin interactions |
| Reactome:R-CEL-373760 | L1CAM interactions |
| Reactome:R-CEL-2682334 | EPH-Ephrin signaling |
| Reactome:R-CFA-9006934 | Signaling by Receptor Tyrosine Kinases |
| Reactome:R-CFA-1433559 | Regulation of KIT signaling |
| Reactome:R-DRE-190242 | FGFR1 ligand binding and activation |
| Reactome:R-DRE-190371 | FGFR3b ligand binding and activation |
| Reactome:R-DRE-5654227 | Phospholipase C-mediated cascade; FGFR3 |
| Reactome:R-DRE-5654743 | Signaling by FGFR4 |
| Reactome:R-DRE-5654712 | FRS-mediated FGFR4 signaling |
| Reactome:R-DRE-186763 | Downstream signal transduction |
| Reactome:R-DRE-1433557 | Signaling by SCF-KIT |
| Reactome:R-DRE-109582 | Hemostasis |
| Reactome:R-DRE-202733 | Cell surface interactions at the vascular wall |
| Reactome:R-DME-177929 | Signaling by EGFR |
| Reactome:R-DME-182971 | EGFR downregulation |
| Reactome:R-DME-190370 | FGFR1b ligand binding and activation |
| Reactome:R-DME-5654693 | FRS-mediated FGFR1 signaling |
| Reactome:R-DME-5654726 | Negative regulation of FGFR1 signaling |
| Reactome:R-DME-1227986 | Signaling by ERBB2 |
| Reactome:R-DME-8863795 | Downregulation of ERBB2 signaling |
| Reactome:R-DME-1251985 | Nuclear signaling by ERBB4 |
| Reactome:R-DME-201681 | TCF dependent signaling in response to WNT |
| Reactome:R-DME-199991 | Membrane Trafficking |
| Reactome:R-DME-8856825 | Cargo recognition for clathrin-mediated endocytosis |
| Reactome:R-DME-422475 | Axon guidance |
| Reactome:R-DME-5252538 | Drosophila signaling pathways |
| Reactome:R-GGA-1433557 | Signaling by SCF-KIT |
| Reactome:R-HSA-8856828 | Clathrin-mediated endocytosis |
| Reactome:R-HSA-373755 | Semaphorin interactions |
| Reactome:R-HSA-373760 | L1CAM interactions |
| Reactome:R-HSA-8853659 | RET signaling |
| Reactome:R-HSA-3000171 | Non-integrin membrane-ECM interactions |
| Reactome:R-HSA-109582 | Hemostasis |
| Reactome:R-HSA-212718 | EGFR interacts with phospholipase C-gamma |
| Reactome:R-HSA-182971 | EGFR downregulation |
| Reactome:R-HSA-5654743 | Signaling by FGFR4 |
| Reactome:R-HSA-5654712 | FRS-mediated FGFR4 signaling |
| Reactome:R-HSA-187037 | Signaling by NTRK1 (TRKA) |
| Reactome:R-HSA-187687 | Signalling to ERKs |
| Reactome:R-HSA-169893 | Prolonged ERK activation events |
| Reactome:R-HSA-198203 | PI3K/AKT activation |
| Reactome:R-HSA-9006115 | Signaling by NTRK2 (TRKB) |
| Reactome:R-HSA-9026519 | Activated NTRK2 signals through RAS |
| Reactome:R-HSA-9032500 | Activated NTRK2 signals through FYN |
| Reactome:R-HSA-9034013 | NTF3 activates NTRK3 signaling |
| Reactome:R-HSA-9603505 | NTRK3 as a dependence receptor |
| Reactome:R-HSA-186797 | Signaling by PDGF |
| Reactome:R-HSA-195399 | VEGF binds to VEGFR leading to receptor dimerization |
| Reactome:R-HSA-194306 | Neurophilin interactions with VEGF and VEGFR |
| Reactome:R-HSA-1306955 | GRB7 events in ERBB2 signaling |
| Reactome:R-HSA-1358803 | Downregulation of ERBB2:ERBB3 signaling |
| Reactome:R-HSA-2428933 | SHC-related events triggered by IGF1R |
| Reactome:R-HSA-8851805 | MET activates RAS signaling |
| Reactome:R-HSA-8874081 | MET activates PTK2 signaling |
| Reactome:R-HSA-8875656 | MET receptor recycling |
| Reactome:R-HSA-416476 | G alpha (q) signalling events |
| Reactome:R-HSA-9013695 | NOTCH4 Intracellular Domain Regulates Transcription |
| Reactome:R-HSA-8848021 | Signaling by PTK6 |
| Reactome:R-HSA-112316 | Neuronal System |
| Reactome:R-HSA-388844 | Receptor-type tyrosine-protein phosphatases |
| Reactome:R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers |
| Reactome:R-HSA-5637812 | Signaling by EGFRvIII in Cancer |
| Reactome:R-HSA-1226099 | Signaling by FGFR in disease |
| Reactome:R-HSA-1839122 | Signaling by activated point mutants of FGFR1 |
| Reactome:R-HSA-1839126 | FGFR2 mutant receptor activation |
| Reactome:R-HSA-8853333 | Signaling by FGFR2 fusions |
| Reactome:R-HSA-1839130 | Signaling by activated point mutants of FGFR3 |
| Reactome:R-HSA-1839128 | FGFR4 mutant receptor activation |
| Reactome:R-HSA-8876384 | Listeria monocytogenes entry into host cells |
| Reactome:R-HSA-212436 | Generic Transcription Pathway |
| Reactome:R-HSA-9022699 | MECP2 regulates neuronal receptors and channels |
| Reactome:R-HSA-168256 | Immune System |
| Reactome:R-MMU-1266738 | Developmental Biology |
| Reactome:R-MMU-416550 | Sema4D mediated inhibition of cell attachment and migration |
| Reactome:R-MMU-445144 | Signal transduction by L1 |
| Reactome:R-MMU-9006934 | Signaling by Receptor Tyrosine Kinases |
| Reactome:R-MMU-180336 | SHC1 events in EGFR signaling |
| Reactome:R-MMU-5654736 | Signaling by FGFR1 |
| Reactome:R-MMU-190374 | FGFR1c and Klotho ligand binding and activation |
| Reactome:R-MMU-5654219 | Phospholipase C-mediated cascade: FGFR1 |
| Reactome:R-MMU-190377 | FGFR2b ligand binding and activation |
| Reactome:R-MMU-5654741 | Signaling by FGFR3 |
| Reactome:R-MMU-5654708 | Downstream signaling of activated FGFR3 |
| Reactome:R-MMU-1307965 | betaKlotho-mediated ligand binding |
| Reactome:R-MMU-5654719 | SHC-mediated cascade:FGFR4 |
| Reactome:R-MMU-187042 | TRKA activation by NGF |
| Reactome:R-MMU-169893 | Prolonged ERK activation events |
| Reactome:R-MMU-9026527 | Activated NTRK2 signals through PLCG1 |
| Reactome:R-MMU-9034015 | Signaling by NTRK3 (TRKC) |
| Reactome:R-MMU-74752 | Signaling by Insulin receptor |
| Reactome:R-MMU-186763 | Downstream signal transduction |
| Reactome:R-MMU-4420097 | VEGFA-VEGFR2 Pathway |
| Reactome:R-MMU-1433557 | Signaling by SCF-KIT |
| Reactome:R-MMU-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) |
| Reactome:R-MMU-6806834 | Signaling by MET |
| Reactome:R-MMU-372790 | Signaling by GPCR |
| Reactome:R-MMU-157118 | Signaling by NOTCH |
| Reactome:R-MMU-195721 | Signaling by WNT |
| Reactome:R-MMU-9006931 | Signaling by Nuclear Receptors |
| Reactome:R-MMU-9018519 | Estrogen-dependent gene expression |
| Reactome:R-MMU-8848021 | Signaling by PTK6 |
| Reactome:R-MMU-5653656 | Vesicle-mediated transport |
| Reactome:R-RNO-388844 | Receptor-type tyrosine-protein phosphatases |
| Reactome:R-RNO-9006934 | Signaling by Receptor Tyrosine Kinases |
| Reactome:R-RNO-5654736 | Signaling by FGFR1 |
| Reactome:R-RNO-190374 | FGFR1c and Klotho ligand binding and activation |
| Reactome:R-RNO-5654219 | Phospholipase C-mediated cascade: FGFR1 |
| Reactome:R-RNO-1307965 | betaKlotho-mediated ligand binding |
| Reactome:R-RNO-5654719 | SHC-mediated cascade:FGFR4 |
| Reactome:R-RNO-187042 | TRKA activation by NGF |
| Reactome:R-RNO-169893 | Prolonged ERK activation events |
| Reactome:R-RNO-9028731 | Activated NTRK2 signals through FRS2 and FRS3 |
| Reactome:R-RNO-9034013 | NTF3 activates NTRK3 signaling |
| Reactome:R-RNO-74751 | Insulin receptor signalling cascade |
| Reactome:R-RNO-74749 | Signal attenuation |
| Reactome:R-RNO-194138 | Signaling by VEGF |
| Reactome:R-RNO-1963642 | PI3K events in ERBB2 signaling |
| Reactome:R-RNO-8863795 | Downregulation of ERBB2 signaling |
| Reactome:R-RNO-2428924 | IGF1R signaling cascade |
| Reactome:R-RNO-6806942 | MET Receptor Activation |
| Reactome:R-RNO-8875878 | MET promotes cell motility |
| Reactome:R-RNO-8875791 | MET activates STAT3 |
| Reactome:R-RNO-1474244 | Extracellular matrix organization |
| Reactome:R-RNO-449836 | Other interleukin signaling |
| Reactome:R-RNO-422475 | Axon guidance |
| Reactome:R-RNO-416572 | Sema4D induced cell migration and growth-cone collapse |
| Reactome:R-RNO-373760 | L1CAM interactions |
| Reactome:R-SSC-400685 | Sema4D in semaphorin signaling |
| Reactome:R-SSC-8851907 | MET activates PI3K/AKT signaling |
| Reactome:R-SSC-8875513 | MET interacts with TNS proteins |
| Reactome:R-SSC-6807004 | Negative regulation of MET activity |
| Reactome:R-BTA-210993 | Tie2 Signaling |
| Reactome:R-CEL-5653656 | Vesicle-mediated transport |
| Reactome:R-CEL-8856828 | Clathrin-mediated endocytosis |
| Reactome:R-CEL-9006934 | Signaling by Receptor Tyrosine Kinases |
| Reactome:R-CEL-182971 | EGFR downregulation |
| Reactome:R-CEL-190373 | FGFR1c ligand binding and activation |
| Reactome:R-CEL-5654708 | Downstream signaling of activated FGFR3 |
| Reactome:R-CEL-74752 | Signaling by Insulin receptor |
| Reactome:R-CEL-77387 | Insulin receptor recycling |
| Reactome:R-CEL-8939211 | ESR-mediated signaling |
| Reactome:R-CEL-400685 | Sema4D in semaphorin signaling |
| Reactome:R-CEL-3000171 | Non-integrin membrane-ECM interactions |
| Reactome:R-CFA-1266738 | Developmental Biology |
| Reactome:R-DRE-190370 | FGFR1b ligand binding and activation |
| Reactome:R-DRE-5654687 | Downstream signaling of activated FGFR1 |
| Reactome:R-DRE-190241 | FGFR2 ligand binding and activation |
| Reactome:R-DRE-190372 | FGFR3c ligand binding and activation |
| Reactome:R-DRE-190322 | FGFR4 ligand binding and activation |
| Reactome:R-DRE-5654228 | Phospholipase C-mediated cascade; FGFR4 |
| Reactome:R-DRE-194138 | Signaling by VEGF |
| Reactome:R-DRE-1433559 | Regulation of KIT signaling |
| Reactome:R-DRE-210993 | Tie2 Signaling |
| Reactome:R-DME-179812 | GRB2 events in EGFR signaling |
| Reactome:R-DME-190236 | Signaling by FGFR |
| Reactome:R-DME-190373 | FGFR1c ligand binding and activation |
| Reactome:R-DME-5654219 | Phospholipase C-mediated cascade: FGFR1 |
| Reactome:R-DME-77387 | Insulin receptor recycling |
| Reactome:R-DME-1358803 | Downregulation of ERBB2:ERBB3 signaling |
| Reactome:R-DME-1253288 | Downregulation of ERBB4 signaling |
| Reactome:R-DME-373755 | Semaphorin interactions |
| Reactome:R-DME-445144 | Signal transduction by L1 |
| Reactome:R-DME-110526 | Insulin receptor mediated signaling |
| Reactome:R-GGA-162582 | Signaling Pathways |
| Reactome:R-GGA-1433559 | Regulation of KIT signaling |
| Reactome:R-GGA-1266738 | Developmental Biology |
| Reactome:R-HSA-5653656 | Vesicle-mediated transport |
| Reactome:R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis |
| Reactome:R-HSA-400685 | Sema4D in semaphorin signaling |
| Reactome:R-HSA-452723 | Transcriptional regulation of pluripotent stem cells |
| Reactome:R-HSA-1474244 | Extracellular matrix organization |
| Reactome:R-HSA-202733 | Cell surface interactions at the vascular wall |
| Reactome:R-HSA-162582 | Signaling Pathways |
| Reactome:R-HSA-179812 | GRB2 events in EGFR signaling |
| Reactome:R-HSA-190236 | Signaling by FGFR |
| Reactome:R-HSA-190322 | FGFR4 ligand binding and activation |
| Reactome:R-HSA-5654228 | Phospholipase C-mediated cascade; FGFR4 |
| Reactome:R-HSA-166520 | Signaling by NTRKs |
| Reactome:R-HSA-187015 | Activation of TRKA receptors |
| Reactome:R-HSA-167044 | Signalling to RAS |
| Reactome:R-HSA-198745 | Signalling to STAT3 |
| Reactome:R-HSA-9024909 | BDNF activates NTRK2 (TRKB) signaling |
| Reactome:R-HSA-9026527 | Activated NTRK2 signals through PLCG1 |
| Reactome:R-HSA-9032759 | NTRK2 activates RAC1 |
| Reactome:R-HSA-9034793 | Activated NTRK3 signals through PLCG1 |
| Reactome:R-HSA-74752 | Signaling by Insulin receptor |
| Reactome:R-HSA-186763 | Downstream signal transduction |
| Reactome:R-HSA-4420097 | VEGFA-VEGFR2 Pathway |
| Reactome:R-HSA-1433557 | Signaling by SCF-KIT |
| Reactome:R-HSA-1963640 | GRB2 events in ERBB2 signaling |
| Reactome:R-HSA-1236394 | Signaling by ERBB4 |
| Reactome:R-HSA-2428928 | IRS-related events triggered by IGF1R |
| Reactome:R-HSA-8851907 | MET activates PI3K/AKT signaling |
| Reactome:R-HSA-8875513 | MET interacts with TNS proteins |
| Reactome:R-HSA-6807004 | Negative regulation of MET activity |
| Reactome:R-HSA-388396 | GPCR downstream signalling |
| Reactome:R-HSA-881907 | Gastrin-CREB signalling pathway via PKC and MAPK |
| Reactome:R-HSA-8939211 | ESR-mediated signaling |
| Reactome:R-HSA-8953897 | Cellular responses to stimuli |
| Reactome:R-HSA-1643713 | Signaling by EGFR in Cancer |
| Reactome:R-HSA-5637810 | Constitutive Signaling by EGFRvIII |
| Reactome:R-HSA-5655302 | Signaling by FGFR1 in disease |
| Reactome:R-HSA-2033519 | Activated point mutants of FGFR2 |
| Reactome:R-HSA-5655332 | Signaling by FGFR3 in disease |
| Reactome:R-HSA-2033515 | t(4;14) translocations of FGFR3 |
| Reactome:R-HSA-5663205 | Infectious disease |
| Reactome:R-HSA-8864260 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors |
| Reactome:R-HSA-1280215 | Cytokine Signaling in Immune system |
| Reactome:R-HSA-449836 | Other interleukin signaling |
| Reactome:R-MMU-449836 | Other interleukin signaling |
| Reactome:R-MMU-3000171 | Non-integrin membrane-ECM interactions |
| Reactome:R-MMU-109582 | Hemostasis |
| Reactome:R-MMU-422475 | Axon guidance |
| Reactome:R-MMU-416572 | Sema4D induced cell migration and growth-cone collapse |
| Reactome:R-MMU-373760 | L1CAM interactions |
| Reactome:R-MMU-177929 | Signaling by EGFR |
| Reactome:R-MMU-180292 | GAB1 signalosome |
| Reactome:R-MMU-190242 | FGFR1 ligand binding and activation |
| Reactome:R-MMU-5654688 | SHC-mediated cascade:FGFR1 |
| Reactome:R-MMU-5654738 | Signaling by FGFR2 |
| Reactome:R-MMU-190375 | FGFR2c ligand binding and activation |
| Reactome:R-MMU-190239 | FGFR3 ligand binding and activation |
| Reactome:R-MMU-5654706 | FRS-mediated FGFR3 signaling |
| Reactome:R-MMU-5654716 | Downstream signaling of activated FGFR4 |
| Reactome:R-MMU-187687 | Signalling to ERKs |
| Reactome:R-MMU-170968 | Frs2-mediated activation |
| Reactome:R-MMU-177504 | Retrograde neurotrophin signalling |
| Reactome:R-MMU-9028731 | Activated NTRK2 signals through FRS2 and FRS3 |
| Reactome:R-MMU-9034013 | NTF3 activates NTRK3 signaling |
| Reactome:R-MMU-74751 | Insulin receptor signalling cascade |
| Reactome:R-MMU-74749 | Signal attenuation |
| Reactome:R-MMU-194138 | Signaling by VEGF |
| Reactome:R-MMU-1433559 | Regulation of KIT signaling |
| Reactome:R-MMU-1963642 | PI3K events in ERBB2 signaling |
| Reactome:R-MMU-8863795 | Downregulation of ERBB2 signaling |
| Reactome:R-MMU-2428924 | IGF1R signaling cascade |
| Reactome:R-MMU-6806942 | MET Receptor Activation |
| Reactome:R-MMU-8875878 | MET promotes cell motility |
| Reactome:R-MMU-8875791 | MET activates STAT3 |
| Reactome:R-MMU-416476 | G alpha (q) signalling events |
| Reactome:R-MMU-201681 | TCF dependent signaling in response to WNT |
| Reactome:R-MMU-199991 | Membrane Trafficking |
| Reactome:R-MMU-112316 | Neuronal System |
| Reactome:R-MMU-388844 | Receptor-type tyrosine-protein phosphatases |
| Reactome:R-RNO-190242 | FGFR1 ligand binding and activation |
| Reactome:R-RNO-5654688 | SHC-mediated cascade:FGFR1 |
| Reactome:R-RNO-5654716 | Downstream signaling of activated FGFR4 |
| Reactome:R-RNO-187687 | Signalling to ERKs |
| Reactome:R-RNO-170968 | Frs2-mediated activation |
| Reactome:R-RNO-177504 | Retrograde neurotrophin signalling |
| Reactome:R-RNO-9034793 | Activated NTRK3 signals through PLCG1 |
| Reactome:R-RNO-74713 | IRS activation |
| Reactome:R-RNO-77387 | Insulin receptor recycling |
| Reactome:R-RNO-194313 | VEGF ligand-receptor interactions |
| Reactome:R-RNO-5218921 | VEGFR2 mediated cell proliferation |
| Reactome:R-RNO-1227986 | Signaling by ERBB2 |
| Reactome:R-RNO-1306955 | GRB7 events in ERBB2 signaling |
| Reactome:R-RNO-1358803 | Downregulation of ERBB2:ERBB3 signaling |
| Reactome:R-RNO-2428933 | SHC-related events triggered by IGF1R |
| Reactome:R-RNO-8851805 | MET activates RAS signaling |
| Reactome:R-RNO-8874081 | MET activates PTK2 signaling |
| Reactome:R-RNO-8875656 | MET receptor recycling |
| Reactome:R-RNO-1280215 | Cytokine Signaling in Immune system |
| Reactome:R-RNO-373755 | Semaphorin interactions |
| Reactome:R-SSC-1266738 | Developmental Biology |
| Reactome:R-SSC-416550 | Sema4D mediated inhibition of cell attachment and migration |
| Reactome:R-SSC-162582 | Signaling Pathways |
| Reactome:R-SSC-6806834 | Signaling by MET |
| WikiPathways:WP5144 | NRP1-triggered signaling pathways in pancreatic cancer |
| WikiPathways:WP5287 | 17q12 copy number variation syndrome |
| WikiPathways:WP5298 | Dravet syndrome: Scn1a-A1783V point mutation model |
| WikiPathways:WP2643 | Nanoparticle-mediated activation of receptor signaling |
| WikiPathways:WP4838 | Regucalcin in proximal tubule epithelial kidney cells |
| WikiPathways:WP4928 | MAPK pathway in congenital thyroid cancer |
| WikiPathways:WP5055 | Burn wound healing |
| WikiPathways:WP2840 | Hair follicle development: cytodifferentiation - part 3 of 3 |
| WikiPathways:WP4389 | Bile acids synthesis and enterohepatic circulation |
| WikiPathways:WP4820 | GDNF/RET signaling axis |
| WikiPathways:WP5181 | Roles of ceramides in development of insulin resistance |
| WikiPathways:WP5322 | CKAP4 signaling pathway map |
| WikiPathways:WP5158 | Urotensin-II-mediated signaling pathway |
| WikiPathways:WP5372 | Involvement of -secretase in neurodegenerative diseases |
| WikiPathways:WP3634 | Insulin signaling in adipocytes (normal condition) |
| WikiPathways:WP2839 | Hair follicle development: organogenesis - part 2 of 3 |
| WikiPathways:WP5242 | Comprehensive IL-17A signaling |
| WikiPathways:WP5347 | IL-26 signaling pathways |
| WikiPathways:WP5373 | Role of hypoxia, angiogenesis, and FGF pathway in OA chondrocyte hypertrophy |
| WikiPathways:WP1984 | Integrated breast cancer pathway |
| WikiPathways:WP3635 | Insulin signaling in adipocytes (diabetic condition) |
| PathBank:SMP0108189 | Insulin Signalling |
| PathBank:SMP0120885 | Rac 1 Cell Motility Signaling Pathway |
| PathBank:SMP0120923 | Growth Hormone Signaling Pathway |
| PathBank:SMP0000420 | Bevacizumab Action Pathway |
| PathBank:SMP0000473 | Gefitinib Action Pathway |
| PathBank:SMP0063810 | EGF Signalling Pathway |
| PathBank:SMP0100484 | Rac 1 cell motility signaling pathway |
| PathBank:SMP0100499 | Rac 1 cell motility signaling pathway |
| PathBank:SMP0000463 | Phosphatidylinositol Phosphate Metabolism |
| PathBank:SMP0000472 | Erlotinib Action Pathway |
| PathBank:SMP0000476 | Trastuzumab Action Pathway |
| PathBank:SMP0063795 | Rac 1 Cell Motility Signaling Pathway |
| PathBank:SMP0108000 | Leucine Stimulation on Insulin Signaling |
| PathBank:SMP0120900 | EGF Signalling Pathway |
| PathBank:SMP0000421 | Vatalanib Action Pathway |
| PathBank:SMP0000474 | Cetuximab Action Pathway |
| PathBank:SMP0000682 | Leucine Stimulation on Insulin Signaling |
| PathBank:SMP0086851 | Bile Acid Indirect Signalling Pathway |
| PathBank:SMP0089975 | g-Secretase Mediated ErbB4 Signalling Pathway |
| PathBank:SMP0120887 | Rac 1 Cell Motility Signaling Pathway |
| PathBank:SMP0120901 | GnRH Signaling Pathway |
| PathBank:SMP0120933 | CXCR4 Signaling Pathway |
| PathBank:SMP0120945 | Ion Channel and Phorbal Esters Signaling Pathway |
| PathBank:SMP0000475 | Panitumumab Action Pathway |
| PathBank:SMP0000391 | Insulin Signalling |
| PathBank:SMP0000582 | Joubert Syndrome |
| PathBank:SMP0087503 | Phosphatidylinositol Phosphate Metabolism |
| PathBank:SMP0063807 | Growth Hormone Signaling Pathway |
| PathBank:SMP0063811 | GnRH Signaling Pathway |